Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
|Articles|October 19, 2020
Pharmacy Times: Week of October 19 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A recap of the exclusive content, award winners, and giveaways from the annual Women Pharmacist Day on October 12, 2020, which will be published on Thursday.
- On Friday, Pharmacy Times will publish an interview with John Beckner, senior director of strategic initiatives at the National Community Pharmacists Association, on the importance of acknowledging the critical role of pharmacists in supporting the US health care system this American Pharmacists Month.
- An interview with Amy Kallo, a PharmD student at Midwestern University, who found that working at a pharmacy during the COVID-19 pandemic brought her closer to her mentor and helped her become more aligned with her professional goals, which will be published on Tuesday.
- On Wednesday, Pharmacy Times will publish an article on the importance of smoking cessation during the coronavirus disease 2019 pandemic, including pharmacologic interventions for smoking cessation, varenicline, and combination nicotine replacement therapy.
Advertisement
Related to this article
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg/d was linked to more kidney failure and higher all-cause mortality.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Over Half of RSV-Related Deaths in Hospitalized Adults Occur After Discharge
2
Caitlin McClain, Peggy Lillis Foundation Board Member, Shares Her Experience With C difficile
3
Early Nirmatrelvir/Ritonavir Linked to Lower Long COVID Risk in High-Risk Outpatients
4
Community Pharmacists Guide Patients New to Glucose Monitoring
5